Cargando…
Disease activity, burden and suffering in patients with ulcerative colitis in the UK cohort recruited into the global ICONIC study
OBJECTIVE: The Understanding the Impact of Ulcerative Colitis and Its Associated Disease Burden on Patients (ICONIC) was a 2-year, global, prospective, observational study assessing disease burden in adults recently diagnosed (≤36 months) with ulcerative colitis (UC) receiving routine outpatient car...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9763636/ https://www.ncbi.nlm.nih.gov/pubmed/36561781 http://dx.doi.org/10.1136/flgastro-2022-102104 |
_version_ | 1784853104179544064 |
---|---|
author | Bhala, Neeraj Hart, Ailsa Watts, David Lewis, Stephen Ghosh, Subrata Hansell, Chris Ahmad, Tariq Van Haaren, Stijn Sensky, Tom |
author_facet | Bhala, Neeraj Hart, Ailsa Watts, David Lewis, Stephen Ghosh, Subrata Hansell, Chris Ahmad, Tariq Van Haaren, Stijn Sensky, Tom |
author_sort | Bhala, Neeraj |
collection | PubMed |
description | OBJECTIVE: The Understanding the Impact of Ulcerative Colitis and Its Associated Disease Burden on Patients (ICONIC) was a 2-year, global, prospective, observational study assessing disease burden in adults recently diagnosed (≤36 months) with ulcerative colitis (UC) receiving routine outpatient care, irrespective of disease severity or treatment. A subanalysis was conducted to understand the UK perspective. DESIGN/METHOD: All eligible consenting patients enrolled in ICONIC from the UK were included in the subanalysis of patient-reported and physician-reported outcomes at baseline and year 2 (Y2). RESULTS: Sixty-three UK patients were included (mean age 43.4 years, 58.7% female). At baseline and Y2, the mean (±SD) Simple Clinical Colitis Activity Index (SCCAI) scores were 3.6 (±3.3) and 1.5 (±1.5); Patient Modified Simple Clinical Colitis Activity Index (P-SSCAI) were 4.9 (±4.0) and 2.6 (±2.6), respectively. Physician-reported Pictorial Representation of Illness and Self Measure (PRISM) median scores (assessing inverse of suffering) were 3.5 (IQR 2.0–6.8) at baseline and 5.5 (IQR 3.6–6.9) at Y2; patient-reported PRISM scores were 4.7 (IQR 2.6–6.9) and 5.4 (IQR 3.2–8.0), respectively. At baseline, SCCAI and P-SCCAI were strongly correlated (r=0.86, p<0.0001), and patient-reported and physician-reported PRISM scores moderately correlated (r=0.67, p<0.0001). At Y2, moderate correlations were observed (SCCAI vs P-SCCAI: r=0.72, p<0.0001; patient-reported vs physician- reported PRISM: r=0.60, p<0.0001). Rating Form of IBD Patient Concerns scores indicated patients’ greatest concerns were with energy level, having an ostomy bag and effects of medication (baseline scores >3.0). CONCLUSIONS: These findings demonstrated the multifaceted burden of disease in patients recently diagnosed with UC in the UK. Agreement between patients and physicians on disease activity/severity varied according to the instrument used. |
format | Online Article Text |
id | pubmed-9763636 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-97636362022-12-21 Disease activity, burden and suffering in patients with ulcerative colitis in the UK cohort recruited into the global ICONIC study Bhala, Neeraj Hart, Ailsa Watts, David Lewis, Stephen Ghosh, Subrata Hansell, Chris Ahmad, Tariq Van Haaren, Stijn Sensky, Tom Frontline Gastroenterol Colorectal OBJECTIVE: The Understanding the Impact of Ulcerative Colitis and Its Associated Disease Burden on Patients (ICONIC) was a 2-year, global, prospective, observational study assessing disease burden in adults recently diagnosed (≤36 months) with ulcerative colitis (UC) receiving routine outpatient care, irrespective of disease severity or treatment. A subanalysis was conducted to understand the UK perspective. DESIGN/METHOD: All eligible consenting patients enrolled in ICONIC from the UK were included in the subanalysis of patient-reported and physician-reported outcomes at baseline and year 2 (Y2). RESULTS: Sixty-three UK patients were included (mean age 43.4 years, 58.7% female). At baseline and Y2, the mean (±SD) Simple Clinical Colitis Activity Index (SCCAI) scores were 3.6 (±3.3) and 1.5 (±1.5); Patient Modified Simple Clinical Colitis Activity Index (P-SSCAI) were 4.9 (±4.0) and 2.6 (±2.6), respectively. Physician-reported Pictorial Representation of Illness and Self Measure (PRISM) median scores (assessing inverse of suffering) were 3.5 (IQR 2.0–6.8) at baseline and 5.5 (IQR 3.6–6.9) at Y2; patient-reported PRISM scores were 4.7 (IQR 2.6–6.9) and 5.4 (IQR 3.2–8.0), respectively. At baseline, SCCAI and P-SCCAI were strongly correlated (r=0.86, p<0.0001), and patient-reported and physician-reported PRISM scores moderately correlated (r=0.67, p<0.0001). At Y2, moderate correlations were observed (SCCAI vs P-SCCAI: r=0.72, p<0.0001; patient-reported vs physician- reported PRISM: r=0.60, p<0.0001). Rating Form of IBD Patient Concerns scores indicated patients’ greatest concerns were with energy level, having an ostomy bag and effects of medication (baseline scores >3.0). CONCLUSIONS: These findings demonstrated the multifaceted burden of disease in patients recently diagnosed with UC in the UK. Agreement between patients and physicians on disease activity/severity varied according to the instrument used. BMJ Publishing Group 2022-06-22 /pmc/articles/PMC9763636/ /pubmed/36561781 http://dx.doi.org/10.1136/flgastro-2022-102104 Text en © Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Colorectal Bhala, Neeraj Hart, Ailsa Watts, David Lewis, Stephen Ghosh, Subrata Hansell, Chris Ahmad, Tariq Van Haaren, Stijn Sensky, Tom Disease activity, burden and suffering in patients with ulcerative colitis in the UK cohort recruited into the global ICONIC study |
title | Disease activity, burden and suffering in patients with ulcerative colitis in the UK cohort recruited into the global ICONIC study |
title_full | Disease activity, burden and suffering in patients with ulcerative colitis in the UK cohort recruited into the global ICONIC study |
title_fullStr | Disease activity, burden and suffering in patients with ulcerative colitis in the UK cohort recruited into the global ICONIC study |
title_full_unstemmed | Disease activity, burden and suffering in patients with ulcerative colitis in the UK cohort recruited into the global ICONIC study |
title_short | Disease activity, burden and suffering in patients with ulcerative colitis in the UK cohort recruited into the global ICONIC study |
title_sort | disease activity, burden and suffering in patients with ulcerative colitis in the uk cohort recruited into the global iconic study |
topic | Colorectal |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9763636/ https://www.ncbi.nlm.nih.gov/pubmed/36561781 http://dx.doi.org/10.1136/flgastro-2022-102104 |
work_keys_str_mv | AT bhalaneeraj diseaseactivityburdenandsufferinginpatientswithulcerativecolitisintheukcohortrecruitedintotheglobaliconicstudy AT hartailsa diseaseactivityburdenandsufferinginpatientswithulcerativecolitisintheukcohortrecruitedintotheglobaliconicstudy AT wattsdavid diseaseactivityburdenandsufferinginpatientswithulcerativecolitisintheukcohortrecruitedintotheglobaliconicstudy AT lewisstephen diseaseactivityburdenandsufferinginpatientswithulcerativecolitisintheukcohortrecruitedintotheglobaliconicstudy AT ghoshsubrata diseaseactivityburdenandsufferinginpatientswithulcerativecolitisintheukcohortrecruitedintotheglobaliconicstudy AT hansellchris diseaseactivityburdenandsufferinginpatientswithulcerativecolitisintheukcohortrecruitedintotheglobaliconicstudy AT ahmadtariq diseaseactivityburdenandsufferinginpatientswithulcerativecolitisintheukcohortrecruitedintotheglobaliconicstudy AT vanhaarenstijn diseaseactivityburdenandsufferinginpatientswithulcerativecolitisintheukcohortrecruitedintotheglobaliconicstudy AT senskytom diseaseactivityburdenandsufferinginpatientswithulcerativecolitisintheukcohortrecruitedintotheglobaliconicstudy |